|OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
|02/06/19||OraSure Announces 2018 Full Year and Fourth Quarter Financial Results|
|BETHLEHEM, Pa., Feb. 06, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the full year and fourth quarter of 2018.
Net revenues for the year ended December 31, 2018 were $181.7 million, a 9% increase from 2017. Net product revenues were $165.4 million, representing 2% growth over 2017.
Net revenues for the fourth quarter ... |
|01/10/19||OraSure Technologies Earnings Conference Call Invitation|
|2018 Fourth Quarter Earnings Conference Call Wednesday, February 6, 2019, 5:00 p.m. ET
BETHLEHEM, Pa., Jan. 10, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2018 fourth quarter financial results, 2019 first quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, February 6, 2019.
February 6, 2019 Schedule
|01/04/19||OraSure Technologies, Inc. Announces Two Acquisitions and Reaffirms Fourth Quarter 2018 Guidance|
|CoreBiome leverages OraSure’s leadership position in microbiome sample collection with end-to-end laboratory services for sample processing, sequencing, and bioinformatics
Novosanis’ urine collection technology expands molecular collection portfolio and advances OraSure’s expertise in non-invasive sampling
BETHLEHEM, Pa., Jan. 04, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, t... |
|01/02/19||OraSure Technologies, Inc.: Updated Release to Clarify Timing of Presentation|
|OraSure Technologies to Present at the 37th Annual J.P. Morgan Healthcare Conference
BETHLEHEM, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 37TH Annual J.P. Morgan Healthcare Conference. The conference will be simultaneously webcast over the Internet.
Dr. Tang is schedule... |
|05/21/19 10:00 a.m. ET|